Fund Overview of Bandhan Healthcare Fund Direct-growth
-
₹273.1 CrAUM
-
₹9.83NAV
-
4.84%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of Bandhan Healthcare Fund Direct-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 6.85% | NA | 6.12% |
Asset Allocation
equities
97.46%debt instruments
0.02%other assets or cash equivalents
2.52%Bandhan Healthcare Fund Direct-growth is one Equity mutual fund offered by Bandhan Mutual Fund. Launched on 28 Nov 2025, the fund aims To create wealth over a long term. Investment predominantly in equity and equity related instruments of pharma, healthcare and allied companies. It manages assets worth ₹273.1 crore as on Tue Mar 31, 2026. The expense ratio stands at 4.84%.About Bandhan Healthcare Fund Direct-growth
The portfolio allocation consists of 97.46% in equities, 0.02% in debt instruments, 2.52% in other assets or cash equivalents.it has delivered a return of 0.00% in the last year, a total return since inception of -1.72%.
When exploring investment options long-term planners generally consider best sip investment based on returns.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | 9.28% | 6.88% | 7.97% | 28.10% | 17.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | 9.28% | 6.88% | 7.97% | 28.10% | 17.25% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | 5.49% | 8.23% | 5.39% | 26.07% | 16.75% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹4,064 | 5.49% | 8.23% | 5.39% | 26.07% | 16.75% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | 9.21% | 6.67% | 7.10% | 27.02% | 16.23% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | 9.21% | 6.67% | 7.10% | 27.02% | 16.23% |
| Mirae Asset Healthcare Fund Direct-growth |
₹2,754 | 6.28% | 10.64% | 10.99% | 25.62% | 16.13% |
| Mirae Asset Healthcare Fund Direct-idcw |
₹2,754 | 6.28% | 10.64% | 10.99% | 25.62% | 16.13% |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | 5.40% | 7.97% | 4.33% | 24.76% | 15.52% |
| SBI Healthcare Opportunities Fund-idcw |
₹4,064 | 5.40% | 7.97% | 4.33% | 24.76% | 15.52% |
More funds from Bandhan Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Bandhan Healthcare Fund Regular-growth
|
₹273 | 6.01% | 6.43% | - | - | - |
|
Bandhan Healthcare Fund Regular-idcw
|
₹273 | 6.01% | 6.43% | - | - | - |
|
Bandhan Healthcare Fund Direct-idcw
|
₹273 | 6.13% | 6.85% | - | - | - |
|
Bandhan Bse Healthcare Index Fund Regular-growth
|
₹16 | 6.69% | 7.76% | -0.22% | 5.05% | - |
|
Bandhan Bse Healthcare Index Fund Direct-growth
|
₹16 | 6.76% | 7.97% | 0.18% | 5.90% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹7,898 | ₹517.06 | 22.10% | 13.33% | 14.44% |
| Nippon India Pharma Fund Direct-growth |
₹7,898 | ₹579.98 | 23.20% | 14.35% | 15.46% |
| Nippon India Pharma Fund-idcw |
₹7,898 | ₹111.66 | 22.10% | 13.33% | 14.44% |
| Nippon India Pharma Fund Direct-idcw |
₹7,898 | ₹158.73 | 23.20% | 14.35% | 15.46% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | ₹39.98 | 27.02% | 16.23% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | ₹43.35 | 28.10% | 17.25% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | ₹23.33 | 27.02% | 16.23% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | ₹26.18 | 28.10% | 17.25% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | ₹438.27 | 24.76% | 15.52% | 12.30% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | ₹505.86 | 26.07% | 16.75% | 13.54% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Reverse Repo | Unspecified | 41.62% | ₹121.36 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.05% | ₹29.31 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.65% | ₹26.36 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.84% | ₹26.06 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 8.76% | ₹25.81 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.68% | ₹25.80 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 8.97% | ₹24.48 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.56% | ₹23.93 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.82% | ₹23.24 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 8.22% | ₹22.97 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.50% | ₹22.11 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.55% | ₹22.01 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.39% | ₹21.79 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.31% | ₹21.73 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.12% | ₹21.16 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.36% | ₹20.57 Cr |
| Cipla Ltd | Healthcare | 6.86% | ₹20.22 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.40% | ₹20.22 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.77% | ₹19.94 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.14% | ₹19.49 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.12% | ₹19.45 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.93% | ₹19.38 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.42% | ₹19.07 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.48% | ₹18.88 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.75% | ₹18.88 Cr |
| Cipla Ltd | Healthcare | 6.31% | ₹18.74 Cr |
| Cipla Ltd | Healthcare | 6.30% | ₹18.38 Cr |
| Cipla Ltd | Healthcare | 6.72% | ₹18.36 Cr |
| Reverse Repo | Unspecified | 6.07% | ₹18.04 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.18% | ₹18.02 Cr |
| Cipla Ltd | Healthcare | 6.01% | ₹16.81 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 5.57% | ₹16.43 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.55% | ₹16.19 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 5.35% | ₹14.96 Cr |
| Reverse Repo | Unspecified | 5.32% | ₹14.86 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.90% | ₹14.56 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.91% | ₹13.42 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.25% | ₹12.40 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.84% | ₹11.42 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.95% | ₹11.04 Cr |
| Lupin Ltd | Healthcare | 3.81% | ₹10.41 Cr |
| Lupin Ltd | Healthcare | 3.51% | ₹10.36 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.43% | ₹10.11 Cr |
| Lupin Ltd | Healthcare | 3.46% | ₹9.69 Cr |
| Lupin Ltd | Healthcare | 3.19% | ₹9.49 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.23% | ₹9.04 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.31% | ₹9.03 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.03% | ₹9.00 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.05% | ₹8.98 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.89% | ₹8.60 Cr |
| Syngene International Ltd | Healthcare | 2.85% | ₹8.46 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.08% | ₹8.42 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.85% | ₹8.32 Cr |
| Global Health Ltd | Healthcare | 2.79% | ₹8.30 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.92% | ₹8.18 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.76% | ₹8.12 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.76% | ₹8.12 Cr |
| Syngene International Ltd | Healthcare | 2.78% | ₹8.10 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.97% | ₹8.10 Cr |
| Global Health Ltd | Healthcare | 2.70% | ₹7.97 Cr |
| Reverse Repo | Unspecified | 2.89% | ₹7.90 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.87% | ₹7.83 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.79% | ₹7.61 Cr |
| Global Health Ltd | Healthcare | 2.64% | ₹7.38 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.48% | ₹7.32 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.59% | ₹7.25 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.39% | ₹7.10 Cr |
| Global Health Ltd | Healthcare | 2.46% | ₹6.73 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.38% | ₹6.65 Cr |
| Reverse Repo | Unspecified | 2.21% | ₹6.50 Cr |
| Syngene International Ltd | Healthcare | 2.20% | ₹6.15 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.05% | ₹6.11 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.03% | ₹5.99 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.02% | ₹5.96 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.00% | ₹5.94 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.00% | ₹5.84 Cr |
| Abbott India Ltd | Healthcare | 1.98% | ₹5.84 Cr |
| Abbott India Ltd | Healthcare | 2.09% | ₹5.70 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.92% | ₹5.66 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.94% | ₹5.66 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.93% | ₹5.63 Cr |
| Syngene International Ltd | Healthcare | 1.86% | ₹5.49 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.83% | ₹5.45 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.85% | ₹5.41 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.82% | ₹5.35 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.83% | ₹5.34 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.82% | ₹5.31 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.89% | ₹5.28 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.92% | ₹5.23 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.76% | ₹5.14 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.83% | ₹5.12 Cr |
| Syngene International Ltd | Healthcare | 1.86% | ₹5.07 Cr |
| Pfizer Ltd | Healthcare | 1.72% | ₹5.06 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.84% | ₹5.02 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.79% | ₹5.01 Cr |
| Pfizer Ltd | Healthcare | 1.68% | ₹4.99 Cr |
| Pfizer Ltd | Healthcare | 1.71% | ₹4.98 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.82% | ₹4.97 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.66% | ₹4.95 Cr |
| Abbott India Ltd | Healthcare | 1.66% | ₹4.93 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.78% | ₹4.86 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.73% | ₹4.83 Cr |
| Pfizer Ltd | Healthcare | 1.73% | ₹4.72 Cr |
| Abbott India Ltd | Healthcare | 1.68% | ₹4.69 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.54% | ₹4.56 Cr |
| Pfizer Ltd | Healthcare | 1.63% | ₹4.56 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.60% | ₹4.36 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.43% | ₹4.21 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.41% | ₹4.11 Cr |
| Sanofi India Ltd | Healthcare | 1.38% | ₹4.09 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.47% | ₹4.02 Cr |
| Sanofi India Ltd | Healthcare | 1.44% | ₹4.02 Cr |
| Sanofi India Ltd | Healthcare | 1.35% | ₹3.97 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.33% | ₹3.93 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.34% | ₹3.75 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.26% | ₹3.72 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.25% | ₹3.70 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.24% | ₹3.69 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.26% | ₹3.68 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.24% | ₹3.68 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.34% | ₹3.66 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.22% | ₹3.64 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.22% | ₹3.62 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.29% | ₹3.61 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.14% | ₹3.37 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.14% | ₹3.33 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.18% | ₹3.31 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.08% | ₹3.22 Cr |
| Sanofi India Ltd | Healthcare | 1.18% | ₹3.21 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.14% | ₹3.19 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.05% | ₹3.06 Cr |
| Abbott India Ltd | Healthcare | 1.03% | ₹3.01 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.01% | ₹2.97 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.05% | ₹2.95 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 0.92% | ₹2.74 Cr |
| Concord Biotech Ltd. | Healthcare | 0.91% | ₹2.69 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 0.96% | ₹2.69 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.89% | ₹2.64 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.88% | ₹2.60 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 0.88% | ₹2.45 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.90% | ₹2.45 Cr |
| Concord Biotech Ltd. | Healthcare | 0.83% | ₹2.44 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 0.81% | ₹2.39 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 0.87% | ₹2.37 Cr |
| Concord Biotech Ltd. | Healthcare | 0.84% | ₹2.35 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 0.84% | ₹2.30 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.82% | ₹2.29 Cr |
| Concord Biotech Ltd. | Healthcare | 0.75% | ₹2.04 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.63% | ₹1.86 Cr |
| Orchid Pharma Ltd | Healthcare | 0.61% | ₹1.82 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.66% | ₹1.81 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.60% | ₹1.74 Cr |
| Orchid Pharma Ltd | Healthcare | 0.60% | ₹1.68 Cr |
| Ipca Laboratories Ltd | Healthcare | 0.59% | ₹1.60 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.54% | ₹1.59 Cr |
| Ipca Laboratories Ltd | Healthcare | 0.52% | ₹1.53 Cr |
| Orchid Pharma Ltd | Healthcare | 0.50% | ₹1.49 Cr |
| Concord Biotech Ltd. | Healthcare | 0.49% | ₹1.42 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.45% | ₹1.25 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.41% | ₹1.22 Cr |
| Orchid Pharma Ltd | Healthcare | 0.42% | ₹1.16 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.36% | ₹0.98 Cr |
| Inventurus Knowledge Solutions Ltd. | Industrials | 0.28% | ₹0.78 Cr |
| Others Mrgn Money | Unspecified | 0.24% | ₹0.69 Cr |
| Inventurus Knowledge Solutions Ltd. | Industrials | 0.23% | ₹0.69 Cr |
| Inventurus Knowledge Solutions Ltd. | Industrials | 0.24% | ₹0.66 Cr |
| Others Mrgn Money | Unspecified | 0.04% | ₹0.11 Cr |
| Others Mrgn Money | Unspecified | 0.03% | ₹0.09 Cr |
| Others Mrgn Money | Unspecified | 0.02% | ₹0.05 Cr |
| Others Mrgn Money | Unspecified | 0.01% | ₹0.04 Cr |
| Net Payables | Unspecified | -0.28% | ₹-0.89 Cr |
| Net Payables | Unspecified | -0.37% | ₹-0.98 Cr |
| Net Payables | Unspecified | -0.57% | ₹-1.70 Cr |
| Net Payables | Unspecified | -0.72% | ₹-2.05 Cr |
| Net Payables | Unspecified | -15.67% | ₹-45.71 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹43.35 | 28.10% | 17.25% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹26.18 | 28.10% | 17.25% | - |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹505.86 | 26.07% | 16.75% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹351.46 | 26.07% | 16.75% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹39.98 | 27.02% | 16.23% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹23.33 | 27.02% | 16.23% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹45.26 | 25.62% | 16.13% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹27.26 | 25.62% | 16.13% | - |
| SBI Healthcare Opportunities Fund-growth |
₹438.27 | 24.76% | 15.52% | - |
| SBI Healthcare Opportunities Fund-idcw |
₹276.09 | 24.76% | 15.52% | - |
Frequently Asked Questions
Bandhan Healthcare Fund Direct-growth
What is the current AUM of Bandhan Healthcare Fund Direct-growth?
As of Tue Mar 31, 2026, Bandhan Healthcare Fund Direct-growth manages assets worth ₹273.1 crore
How has Bandhan Healthcare Fund Direct-growth performed recently?
- 3 Months: 6.85%
- 6 Months: 0.00%
What is the portfolio composition of Bandhan Healthcare Fund Direct-growth?
Equity: 97.46%, Debt: 0.02%, Others: 2.52%.
What is the market-cap allocation of Bandhan Healthcare Fund Direct-growth?
Large Cap: 48.22%, Mid Cap: 20.46%, Small Cap: 31.32%.
Which are the top companies Bandhan Healthcare Fund Direct-growth has invested in?
- Reverse Repo – 41.62% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.05% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 9.65% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 8.84% of the fund's portfolio
- Apollo Hospitals Enterprise Ltd – 8.76% of the fund's portfolio
Which are the major sectors Bandhan Healthcare Fund Direct-growth focuses on?
- Healthcare – 448.99% of the fund's portfolio
- Unspecified – 40.84% of the fund's portfolio
- Financial – 5.16% of the fund's portfolio
- Industrials – 5.01% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





